Hims & Hers Health, Inc. (BMV:HIMS)
Mexico · Delayed Price · Currency is MXN 936.00
-29.76 (-3.08%)
At close: Aug 11, 2025, 2:00 PM CST
Lumos Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2020 |
Net Income | 193.6 | 126.04 | -23.55 | -65.68 | -107.66 | -18.11 | Upgrade |
Depreciation & Amortization | 29.19 | 17.09 | 9.52 | 7.47 | 4.08 | 1.06 | Upgrade |
Other Amortization | 1.05 | - | - | - | 0.14 | 0.32 | Upgrade |
Asset Writedown & Restructuring Costs | - | 0.11 | 0.43 | 1.13 | - | - | Upgrade |
Loss (Gain) From Sale of Investments | -3.13 | -4.36 | -5.69 | 0.15 | 2.17 | 0.33 | Upgrade |
Stock-Based Compensation | 109.83 | 92.32 | 66.08 | 42.82 | 67.21 | 5.83 | Upgrade |
Other Operating Activities | -64.46 | -58.75 | 5.87 | 1.78 | -3.8 | 3.91 | Upgrade |
Change in Inventory | -100.86 | -41.61 | -0.9 | -8 | -9.63 | 0.67 | Upgrade |
Change in Accounts Payable | 32.7 | 43.71 | 7.32 | 12.72 | 9.85 | 0.83 | Upgrade |
Change in Unearned Revenue | 77.43 | 67.55 | 6.26 | -1.72 | 1.41 | 0.52 | Upgrade |
Change in Other Net Operating Assets | -13.71 | 8.97 | 8.14 | -17.2 | 1.82 | 2.17 | Upgrade |
Operating Cash Flow | 261.63 | 251.08 | 73.48 | -26.53 | -34.41 | -2.48 | Upgrade |
Operating Cash Flow Growth | 106.64% | 241.69% | - | - | - | - | Upgrade |
Capital Expenditures | -129.25 | -41.66 | -17.22 | -2.71 | -0.83 | -1.74 | Upgrade |
Cash Acquisitions | -20.5 | -15.4 | - | -0.46 | -46.47 | - | Upgrade |
Sale (Purchase) of Intangibles | -12.87 | -11.1 | -9.27 | -4.53 | -4.18 | -2.5 | Upgrade |
Investment in Securities | 81.11 | 49.1 | 14.39 | 42.41 | -104.79 | -35.47 | Upgrade |
Investing Cash Flow | -81.5 | -19.05 | -12.11 | 34.7 | -156.27 | -39.7 | Upgrade |
Long-Term Debt Repaid | - | - | - | - | - | -1.52 | Upgrade |
Net Debt Issued (Repaid) | 970 | - | - | - | - | -1.52 | Upgrade |
Issuance of Common Stock | 22.26 | 30.89 | 4.62 | 3.42 | 275.92 | 0.68 | Upgrade |
Repurchase of Common Stock | -127.74 | -135.54 | -16.1 | -3.9 | -28.03 | - | Upgrade |
Other Financing Activities | -50.84 | -3.19 | - | -32.65 | -12.85 | -3.36 | Upgrade |
Financing Cash Flow | 813.68 | -107.85 | -11.48 | -33.13 | 235.04 | 47.74 | Upgrade |
Foreign Exchange Rate Adjustments | 1 | -0.27 | -0.01 | -0.05 | -0.07 | -0.01 | Upgrade |
Net Cash Flow | 994.8 | 123.92 | 49.89 | -25.01 | 44.29 | 5.55 | Upgrade |
Free Cash Flow | 132.37 | 209.43 | 56.26 | -29.25 | -35.24 | -4.22 | Upgrade |
Free Cash Flow Growth | 31.18% | 272.23% | - | - | - | - | Upgrade |
Free Cash Flow Margin | 6.57% | 14.18% | 6.45% | -5.55% | -12.96% | -2.83% | Upgrade |
Free Cash Flow Per Share | 0.54 | 0.88 | 0.27 | -0.14 | -0.19 | -0.12 | Upgrade |
Cash Interest Paid | - | - | - | - | - | 0.01 | Upgrade |
Cash Income Tax Paid | 27.5 | 7.92 | 1.11 | 0.64 | 0.34 | 0.22 | Upgrade |
Levered Free Cash Flow | 93.82 | 178.69 | 66.65 | -44.35 | 52.46 | -14 | Upgrade |
Unlevered Free Cash Flow | 93.49 | 178.69 | 66.65 | -44.35 | 52.32 | -14.33 | Upgrade |
Change in Working Capital | -4.45 | 78.62 | 20.82 | -14.2 | 3.46 | 4.19 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.